Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 3 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.


Player Avatar Kvedarna (99.54) Submitted: 11/4/2013 7:39:10 PM : Underperform Start Price: $2.84 CYTX Score: +13.21

Sell on news

Member Avatar Kvedarna (99.54) Submitted: 11/6/2013 10:22:04 AM
Recs: 0

My idea was right, execution sloppy.

Featured Broker Partners